StockData
Exelixis, Inc. logo

Exelixis, Inc. (EXEL) stock

EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/301% above fair value
$69.00−0.84 (-1.20%)

Close on Nov 13, 2026Market cap $16.84BP/E 20.7Yield –

Exelixis gross margin

Gross margin is gross profit as a percentage of revenue.

Exelixis's gross margin for the twelve months ending Oct 2, 2026 was 96.3%. For fiscal 2025 it was 96.4%, against 96.5% the year before. The highest annual figure on record is 100.0% in fiscal 2011.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Jan 2, 202696.4%−0.1
FY2024Jan 3, 202596.5%+0.4
FY2023Dec 29, 202396.0%−0.4
FY2022Dec 30, 202296.4%+0.1
FY2021Dec 31, 202196.3%−0.0
FY2020Jan 1, 202196.3%−0.3
FY2019Jan 3, 202096.6%−0.3
FY2018Dec 28, 201896.9%+0.2
FY2017Dec 29, 201796.7%+0.1
FY2016Dec 31, 201696.6%+7.1
FY2015Dec 31, 201589.5%−2.3
FY2014Dec 31, 201491.9%−4.6
FY2013Dec 31, 201396.4%−3.6
FY2012Dec 31, 2012100.0%+0.0
FY2011Dec 31, 2011100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Oct 2, 202696.0%−0.9
Q2 FY2026Jul 3, 202696.7%+0.1
Q1 FY2026Apr 3, 202696.7%+0.2
Q4 FY2025Jan 2, 202695.6%−0.9
Q3 FY2025Oct 3, 202596.9%+0.1
Q2 FY2025Jul 4, 202596.6%−0.7
Q1 FY2025Apr 4, 202596.5%+1.5
Q4 FY2024Jan 3, 202596.5%+1.0
Q3 FY2024Sep 27, 202496.8%+0.8
Q2 FY2024Jun 28, 202497.2%+1.0
Q1 FY2024Mar 29, 202495.0%−1.5
Q4 FY2023Dec 29, 202395.5%−0.8
Q3 FY2023Sep 29, 202396.0%−0.3
Q2 FY2023Jun 30, 202396.2%−0.6
Q1 FY2023Mar 31, 202396.5%+0.2
Q4 FY2022Dec 30, 202296.2%−0.9
Q3 FY2022Sep 30, 202296.3%−0.1
Q2 FY2022Jul 1, 202296.8%+0.7
Q1 FY2022Apr 1, 202296.3%+1.2
Q4 FY2021Dec 31, 202197.1%+26.3
Q3 FY2021Oct 1, 202196.4%+27.2
Q2 FY2021Jul 2, 202196.1%+30.8
Q1 FY2021Apr 2, 202195.1%+13.8
Q4 FY2020Jan 1, 202170.8%−5.9
Q3 FY2020Oct 2, 202069.2%+1.4
Q2 FY2020Jul 3, 202065.3%−12.1
Q1 FY2020Apr 3, 202081.3%+1.5
Q4 FY2019Jan 3, 202076.7%+2.9
Q3 FY2019Sep 27, 201967.8%−1.2
Q2 FY2019Jun 28, 201977.5%+2.3
Q1 FY2019Mar 29, 201979.9%+19.7
Q4 FY2018Dec 28, 201873.9%−2.3
Q3 FY2018Sep 28, 201869.0%+8.9
Q2 FY2018Jun 29, 201875.1%−10.7
Q1 FY2018Mar 30, 201860.2%−21.0
Q4 FY2017Dec 29, 201776.2%+11.7
Q3 FY2017Sep 30, 201760.2%–
Q2 FY2017Jun 30, 201785.8%–
Q1 FY2017Mar 31, 201781.2%–
Q4 FY2016Dec 31, 201664.5%–

More Exelixis figures

See a number that looks wrong?